Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChemBridge Research Laboratories was a San Diego-based discovery chemistry contract research organization focused on early-stage small molecule drug discovery. Founded in 2000 as a spin-off of ChemBridge, the company specialized in medicinal chemistry, high-throughput chemistry, and rapid custom hit-to-lead follow-up libraries for pharmaceutical and biotech partners. Historical materials describe collaborations with large pharma companies including Pfizer, Merck, and AstraZeneca, and position CRL as a center of excellence for ultra-fast turnaround chemistry services. The entity appears to have operated as a specialized research arm within the broader ChemBridge group rather than as a developer of its own clinical therapeutics pipeline. Current evidence for an active standalone operating presence is limited, while ChemBridge Corporation remains active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChemBridge Research Laboratories.